Marina Chiara Garassino to Proton Pump Inhibitors
This is a "connection" page, showing publications Marina Chiara Garassino has written about Proton Pump Inhibitors.
Connection Strength
0.091
-
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. Eur J Cancer. 2021 06; 150:224-231.
Score: 0.046
-
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. J Immunother Cancer. 2021 04; 9(4).
Score: 0.045